Introduction {#s1}
============

Locally relevant reference ranges for commonly used biochemical and haematological parameters are essential for screening and safety follow up of trial participants as well as for routine clinical management of patients. However, reference values being used in most laboratories in African countries have been obtained from the literature, reagent inserts accompanying the reagent kits or instrument manuals [@pone.0036308-Koram1]. These values more often than not have been derived from Caucasian populations of industrialised countries and may not be applicable in most local settings. Factors such as age, gender [@pone.0036308-Buchanan1], ethnicity [@pone.0036308-Horn1] and environment including altitude and geo-chemicals [@pone.0036308-ElHazmi1] affect the measurements determined in different populations. Published literature has confirmed that many of the reference values obtained from the developed countries differ significantly from what pertains in most African localities [@pone.0036308-Koram1], [@pone.0036308-Adetifa1], [@pone.0036308-Lugada1], [@pone.0036308-Karita1], [@pone.0036308-Quinto1]; thus making it necessary to establish locally relevant values. The Clinical and Laboratory Standards Institute (CLSI) [@pone.0036308-CLSI1] and the International Federation for Clinical Chemistry (IFCC) [@pone.0036308-Solberg1] recommend that each laboratory establishes its own reference values.

The Kintampo Health Research Centre (KHRC) located in Central Ghana has been undertaking Phase II/III drugs and vaccines trials since 2003 and plans soon to add Phase I trials in infectious diseases. Locally relevant biochemical and haematological reference values for the population are needed in determining eligibility of participants being enrolled into future studies and also for monitoring of the onset of any adverse events during a trial. Availability of such reference values in the locality would also assist physicians in the management of patients. This study was, thus, aimed at establishing reference values for commonly used haematological and biochemical parameters in the population within the Kintampo North Municipality and Kintampo South District.

Methods {#s2}
=======

Study Site {#s2a}
----------

The study was carried out in the Kintampo North Municipality and Kintampo South District of the Brong Ahafo Region of Ghana ([Figure 1](#pone-0036308-g001){ref-type="fig"} and [Figure 2](#pone-0036308-g002){ref-type="fig"}). The studied area is located between Latitudes 7°43′N and 8°44′N and Longitudes 1°25′W and 2°1′W. It lies within the forest-savannah transitional ecological zone and has an elevation ranging between 60 and 150 m above sea level. It is made up of a resident population of about 140,000. The Kintampo Health Research Centre maintains a Health and Demographic Surveillance System (HDSS) that records detailed demographics of all residents including pregnancies, births, deaths and migrations (in and out) at 4 monthly intervals. All the compounds have been digitized making the selection and tracing of individuals to their homes easy.

![Map of the study area.](pone.0036308.g001){#pone-0036308-g001}

![Map of study communities.](pone.0036308.g002){#pone-0036308-g002}

Selection of reference population {#s2b}
---------------------------------

The communities and individuals who participated in this study were randomly selected from the HDSS human population using the Visual FoxPro software. Community meetings were held to explain the objectives of the study to the opinion leaders and other community members.

Those selected through the randomisation were invited to a central location where individual consenting, screening and blood collections were carried out. Inclusion into the study was based on willingness of the individual to participate in the study (demonstrated by the completion and signing/thumbprinting of the consent form and willingness to provide the samples required), general good health (as determined by a clinician\'s medical history and physical examination, and residence in the study area for at least 3 months. Individuals with evidence of acute or chronic respiratory, cardiovascular, gastrointestinal, hepatic or genitourinary conditions, history of blood donation/transfusion within the immediate past three months, hospitalisation within the immediate past one month, or any other findings that in the opinion of the examining clinician may compromise on the assessment of the laboratory parameters of interest in this study were excluded. Those assessed to be pregnant (either clinically or by positive urine β-HCG test) and lactating mothers were all excluded.

Laboratory analysis {#s2c}
-------------------

Venous blood samples were collected from the antecubital fossa, dispensed into a 2 ml K~3~EDTA, a 5 ml SST tubes with gel and 1 ml Fluoride-EDTA for haematology, biochemistry and glucose analysis, respectively. Sample tubes were from Becton Dickinson (Plymouth, United Kingdom). Haematological analysis (complete blood count with 3-part differential) was performed using previously validated ABX Micros 60 analysers (Horiba-ABX, Montpellier, France). Calibrators and controls were obtained from the instrument manufacturer. Analysis of samples was performed within 8 hours of blood draw.

Samples for biochemical analysis were allowed to clot for at least 60 minutes, centrifuged and the serum collected. Serum was analysed within 24 hours after collection. If testing was delayed, serum was stored frozen at −80°C and subjected to a single freeze-thaw cycle at the time of analysis. The Vitalab Selectra E Clinical Chemistry analyser (Vital Scientific, The Netherlands) was used to perform the analysis. Test tubes for the clinical chemistry analysis were from Vital Scientific, The Netherlands. Reagents, calibrators and controls were from Elitech Diagnostics (Sees, France). Electrolytes (chloride, potassium and sodium) were analysed using the Humalyte Electrolyte analyser (Human Diagnostics, Germany). Reagents were from the manufacturer of the instrument.

Normal and abnormal controls were run daily. No analysis was done if controls were out of range. In addition to the internal quality assessment, the laboratory participates in external quality assessments for haematology and clinical chemistry both with the College of American Pathologists (CAP) and the United Kingdom National External Quality Assessment Scheme (UK NEQAS). The laboratory complies with the principles of Good Clinical Laboratory Practice [@pone.0036308-Stevens1], [@pone.0036308-Ezzelle1]. Individuals with abnormal clinical or laboratory test results were referred for appropriate care and treatment.

Between-run precision for the analytes were assessed using at least 20 measurements made on separate days using normal control samples. The mean, standard deviation (SD) and coefficient of variation (CV) were calculated for each analyte. Coefficients of variation (CVs) were compared to those quoted in the analyser manuals and reagent inserts.

Data Management and Statistical Analysis {#s2d}
----------------------------------------

Data were recorded on questionnaires, double-entered into a Visual FoxPro 9.0 database and verified. Data analysis was carried out using Stata 11 (Stata Corp, College Park, TX, USA). The 2.5^th^ and 97.5^th^ percentiles were determined non-parametrically. This was according to the CLSI/IFCC guidelines on defining, establishing and verifying reference intervals in the clinical laboratory [@pone.0036308-CLSI1]. To obtain these intervals, a minimum of 120 observations were required for each analyte within each subgroup. Outliers within each subgroup were identified using the Dixon method [@pone.0036308-CLSI1]. Briefly, the extreme values were retained in the distribution if D/R\<0.33, where D is the absolute difference between the most extreme distribution and the next value and R is the Range (maximum -- minimum). Reference values were determined separately for males, females and combined gender. Differences between genders were tested using the Mann-Whitney test. The values defined were compared with the recommended reference values (based on a North American population) provided in the ABX Micros 60 Haematology User Manual [@pone.0036308-ABX1] and Elitech Diagnostics chemistry reagent inserts, respectively.

Ethical Considerations {#s2e}
----------------------

This study was approved by Ethics Committees of the Kintampo Health Research Centre, the Noguchi Memorial Institute for Medical Research and the Ghana Health Service. Written informed consent was obtained from each participant prior to involving them in the study.

Results {#s3}
=======

A total of 691 randomly selected adults made up of 351 males and 340 females between the ages of 18 and 59 years (mean = 37 years) were screened during the survey. Out of this, 625 individuals (316 males and 309 females) with a mean age of 36 years were enrolled. Tobacco use among all males screened was 64 (9.26%) out of which 52 (8.3%) were among those enrolled. None of the females screened and/or enrolled was a smoker. Screened and enrolled males and females who take alcohol were 107 (33.75%) and 34 (10.97%) respectively. Forty-three (6.2%) of the screened population were taking prescribed medication and were excluded from the study.

Reference Values {#s3a}
----------------

Median and 95% reference values (2.5^th^--97.5^th^ percentiles) for Haematology and Biochemistry are shown in [Tables 1](#pone-0036308-t001){ref-type="table"} and [2](#pone-0036308-t002){ref-type="table"}, respectively. Males had significantly higher haemoglobin values of 113--164 against 88--144 g/L for females (p\<0.0001), haematocrit of 33.2--50.5 against 26.4--45.0% (p\<0.0001) and red blood cells (RBC) of 3.79--5.96 against 3.09--5.30×10^12^/L (p\<0.0001) compared to females. On the other hand, platelets were significantly higher in females with 89--403 against 88--352×10^9^/L for males (p\<0.0001). For the biochemical values, males had significantly higher alanine aminotransferase (ALT) of 8--54 against 6--51 U/L (p\<0.0001), aspartate aminotransferase (AST) of 17--60 against 13--48 U/L (p\<0.0001), alkaline phosphatase (ALP) of 101--353 against 82--293 U/L (p\<0.0001), Creatine kinase (CK) of 93--786 against 58--476 U/L (p\<0.0001), gamma glutamyltransferase (GGT) of 9--71 against 6--53 U/L (p\<0.0001), Creatinine of 56--119 against 47--110 µmol/L (p\<0.0001), Iron of 6.0--32.8 against 5.4--27.8 µmol/L (p\<0.0001), and Uric acid of 126--418 against 83--381 µmol/L (p\<0.0001), compared to the females. Females, however, had significantly higher Cholesterol levels of 2.1--5.6 against 1.8--5.6 mmol/L for males (p\<0.0001).

10.1371/journal.pone.0036308.t001

###### Haematology reference values for Kintampo.

![](pone.0036308.t001){#pone-0036308-t001-1}

  Analyte           Unit     Males   Females   Combined males and Females                                                      
  -------------- ---------- ------- --------- ---------------------------- ----- ------ ------------ ----- ------ ------------ ----------
  Haemoglobin       g/L       316      139              113--164            308   123     88--144     624   131     98--160     \<0.0001
  Haematocrit        \%       316     42.2             33.2--50.5           309   36.9   26.4--45.0   625   39.4   28.9--48.7   \<0.0001
  RBC             ×10^12^     316     4.84             3.79--5.96           307   4.32   3.09--5.30   623   4.57   3.39--5.83   \<0.0001
  MCV                fl       316      88                70--98             309    86      73--96     625    87      72--97      0.0192
  MCH                pg       316     29.1             22.7--33.5           307   28.4   22.3--33.6   623   28.6   22.6--33.5    0.1448
  MCHC              g/dL      315     33.1             30.6--36.0           305   33.1   30.4--36.5   620   33.1   30.5--36.2    0.3621
  RDW                \%       316     13.6             11.5--16.7           309   13.4   11.4--16.8   625   13.5   11.5--16.7    0.2064
  Platelets       ×10^9^/L    316      208              88--352             309   224     89--403     625   216     89--380     \<0.0001
  PDW                \%       315     15.8              12--23.4            308   15.7   12.6--22.9   623   15.7   12.6--23.0    0.5511
  WBC, Total      ×10^9^/L    311      5.5              3.5--9.2            309   5.3     3.4--9.3    620   5.4     3.4--9.2     0.0218
  Lymphocytes        \%       315      41              24.0--57.2           309   42.3   26.9--58.3   624   41.6   25.2--57.7    0.0430
  Lymphocytes     ×10^9^/L    316      2.2              1.2--5.2            308   2.1     1.2--4.4    624   2.1     1.2--4.4     0.2046
  Monocytes          \%       316      9.5             5.7--17.4            309   8.4    5.0--14.4    625   8.9    5.3--16.3    \<0.0001
  Monocytes       ×10^9^/L    316      0.5              0.2--1.4            308   0.4     0.2--0.9    624   0.4     0.2--1.0     0.0002
  Granulocytes       \%       316     48.6             30.2--69.9           309   48.5   33.3--67.5   625   48.5   32.0--68.1    0.8643
  Granulocytes    ×10^9^/L    313      2.7              1.5--5.9            309   2.7     1.4--5.5    622   2.7     1.5--5.6     0.1943

Med: Median.

Mann-Whitney test for differences in between males and females.

10.1371/journal.pone.0036308.t002

###### Biochemistry reference values for Kintampo.

![](pone.0036308.t002){#pone-0036308-t002-2}

  Analyte (Unit)                Males   Females   Combined males and Females                                                      
  ---------------------------- ------- --------- ---------------------------- ----- ------ ------------ ----- ------ ------------ ----------
  Enzymes                                                                                                                         
  ALT (U/L)                      303      23                8--54              300    17      6--51      603    20      7--51      \<0.0001
  AST (U/L)                      300      30                17--60             288    23      13--48     588    26      14--51     \<0.0001
  ALP (U/L)                      293      178              101--353            302   155     82--293     595   160     85--241     \<0.0001
  Amylase (U/L)                  313      69               34--137             308    66     30--139     621    67     32--139      0.0089
  Creatine Kinase (U/L)          302      249              93--786             288   165     58--476     590   190     66--532     \<0.0001
  GGT (U/L)                      302      21                9--71              298    16      6--53      600    19      7--61      \<0.0001
  LDH (U/L)                      275      421              274--745            248   389     214--688    523   406     223--723     0.0002
  Serum Proteins                                                                                                                  
  Protein, Total (g/L)           296     72.5             46.7--86.4           282   73.4   55.2--86.9   578   72.9   50.6--86.7    0.1253
  Albumin (g/L)                  315     42.5             32.7--49.8           307   42.2   33.5--50.4   622   42.3   33.0--49.9    0.7558
  Metabolism                                                                                                                      
  Bilirubin, Total (µmol/L)      310     11.3             3.8--32.0            305   9.4    2.7--26.6    605   9.9    2.9--25.8     0.0006
  Bilirubin, Direct (µmol/L)     189      2.9              0.9--4.1            213   2.4     0.7--3.8    402   2.6     0.8--4.0    \<0.0001
  Cholesterol (mmol/L)           315      3.2              1.8--5.0            307   3.5     2.1--5.6    622   3.3     2.0--5.4    \<0.0001
  Glucose (mmol/L)               315      4.8              3.5--6.3            307   4.8     3.7--6.6    622   4.8     3.6--6.4     0.5790
  Iron (µmol/L)                  309     15.0             6.0--32.8            296   13.5   5.4--27.8    605   14.1   5.5--30.6     0.0004
  Triglycerides (mmol/L)         314      0.9              0.4--2.2            305   0.9     0.4--2.1    619   0.9     0.4--2.2     0.1388
  Kidney Function                                                                                                                 
  Urea (mmol/L)                  315      2.7              0.9--6.2            307   2.5     0.9--5.4    622   2.5     0.9--5.7     0.0066
  Creatinine (µmol/L)            312      85               56--119             303    74     47--110     615    80     49--118     \<0.0001
  Uric Acid (µmol/L)             314      243              126--418            306   181     83--381     620   216     91--399     \<0.0001
  Serum Electrolytes                                                                                                              
  Chloride (mmol/l)              271      107              101--115            260   108       113       531   107     102--114     0.1609
  Phosphorus (mmol/L)            315      1.1              0.7--1.5            307   1.1     0.8--1.5    622   1.1     0.7--1.5     0.0202
  Potassium (mmol/L)             295      4.5              3.6--5.2            288   4.3     3.4--5.1    583   4.4     3.6--5.2    \<0.0001
  Sodium (mmol/L)                276      144              135--151            265   145     135--150    541   144     135--150     0.1080

Med: Median ; NA: Not available.

Mann-Whitney test for differences between males and females.

The column percentage out-of range (% OOR) in [Tables 3](#pone-0036308-t003){ref-type="table"} and [4](#pone-0036308-t004){ref-type="table"} shows the proportion of normal adults in the Kintampo area who would have been classified as having abnormal haematology and biochemistry results when compared with the recommended reference values (based on a north American population) provided in the ABX Micros 60 Haematology User Manual [@pone.0036308-ABX1] and Elitech Diagnostics reagent inserts, respectively. Out of range values for haematology ranged between 13 and 96% with parameters such as Haemoglobin, Haematocrit, RBC, mean cell volume (MCV), mean cell haemoglobin (MCH), mean cell haemoglobin concentration (MCHC) and white blood cell (WBC) predominantly on the lower side of the comparison values. OOR values for biochemistry were high for Amylase (28% and 18%), CK (74% and 58%), lactate dehydrogenase (LDH) (37% and 28%), Protein (34% and 31%), Total Bilirubin (23% each), Urea (25% and 32%), Uric Acid (30% and 36%) and Phosphorus (23% and 24%) for males and females, respectively. [Tables 5](#pone-0036308-t005){ref-type="table"} and [6](#pone-0036308-t006){ref-type="table"} show a comparison of haematology and biochemistry reference values established for Kintampo with values from other studies. Between-run precision for the haematology and clinical chemistry assays are presented in [Tables 7](#pone-0036308-t007){ref-type="table"} and [8](#pone-0036308-t008){ref-type="table"}, respectively. The methods used for the various clinical chemistry analytes are also shown in [Table 8](#pone-0036308-t008){ref-type="table"}.

10.1371/journal.pone.0036308.t003

###### Haematology out of range (OOR) values based on comparison with ABX values.

![](pone.0036308.t003){#pone-0036308-t003-3}

  Analyte           Unit       Males      Females              
  -------------- ---------- ------------ --------- ----------- ------
  Haemoglobin       g/L       135--165     37.0     120--150    42.6
  Haematocrit        \%        41--50      41.6      37--45     53.1
  RBC             ×10^12^    4.37--5.63    26.6     3.9--5.10   27.7
  MCV                fl       83--101      23.7      84--94     39.5
  MCH                pg        26--34      14.3      27--34     25.5
  MCHC              g/dL       32--35      26.4      32--35     31.8
  RDW                \%        12--16      13.6      12--14     43.7
  Platelets       ×10^9^/L    145--355     16.1     150--330    20.1
  PDW                \%          NA         NA         NA        NA
  WBC, Total      ×10^9^/L    4.7--9.6     26.1     4.9--12.3   38.9
  Lymphocytes        \%        23--47      22.9      19--41     56.3
  Lymphocytes     ×10^9^/L       NA         NA         NA        NA
  Monocytes          \%         3--6       95.9       2--6      90.1
  Monocytes       ×10^9^/L       NA         NA         NA        NA
  Granulocytes       \%        49--74      52.2      53--79     68.6
  Granulocytes    ×10^9^/L       NA         NA         NA        NA

NA: Not available.

10.1371/journal.pone.0036308.t004

###### Biochemistry out of range (OOR) values based on comparison with values from Elitech reagent inserts.

![](pone.0036308.t004){#pone-0036308-t004-4}

  Analyte (Unit)                  Males     Females              
  ---------------------------- ----------- --------- ----------- ------
  Enzymes                                                        
  ALT (U/L)                       0--40      11.8       0--40     5.6
  AST (U/L)                       0--46      14.9       0--46     5.2
  ALP (U/L)                      0--270      16.6      0--240     10.8
  Amylase (U/L)                   0--90      28.0       0--90     18.2
  Creatine Kinase (U/L)          0--171      74.2      0--145     58.3
  GGT (U/L)                       0--55      11.4       0--38     4.9
  LDH (U/L)                     235--470     36.6     235--470    27.6
  Serum Proteins                                                 
  Protein, Total (g/L)           60--78      33.8      60--78     31.2
  Albumin (g/L)                  35--52       4.8      35--52     5.5
  Metabolism                                                     
  Bilirubin, Total (µmol/L)       5--21      22.7       5--21     22.5
  Bilirubin, Direct (µmol/L)      0--4        2.1       0--4      0.5
  Cholesterol (mmol/L)            0--5        1.9       0--5      8.1
  Glucose (mmol/L)              4.0--6.0     15.3     4.0--6.0    12.0
  Iron (µmol/L)                 9.0--30.0    16.5     9.0--30.0   16.5
  Triglycerides (mmol/L)         0--1.7       6.4      0--1.7     6.2
  Kidney Function                                                
  Urea (mmol/L)                 2.0--7.0     25.0     2.0--7.0    31.6
  Creatinine (µmol/L)            71--115     21.6      53--106    8.9
  Uric Acid (µmol/L)            208--428     29.6     155--357    36.3
  Serum Electrolytes                                             
  Chloride (mmol/l)                NA         NA         NA        NA
  Phosphorus (mmol/L)           0.9--1.5     23.2     0.9--1.5    23.7
  Potassium (mmol/L)               NA         NA         NA        NA
  Sodium (mmol/L)                  NA         NA         NA        NA

NA: Not available.

10.1371/journal.pone.0036308.t005

###### Comparison of adult haematological reference values obtain from this study against others.

![](pone.0036308.t005){#pone-0036308-t005-5}

  Analyte              Unit      Present Study   Southern Ghana [@pone.0036308-Koram1]   Kenya [@pone.0036308-Kibaya1]   Eastern & Southern Africa [@pone.0036308-Karita1]   Mbeya, Tanzania [@pone.0036308-Saathoff1]   USA [@pone.0036308-Kratz1]
  ----------------- ----------- --------------- --------------------------------------- ------------------------------- --------------------------------------------------- ------------------------------------------- ----------------------------
  Haemoglobin (M)       g/L        113--164                    117--165                             83--113                                  122--177                                        137--177                             135--175
  Haemoglobin (F)       g/L         88--144                     91--140                             59--100                                   95--158                                        111--157                             120--160
  Haematocrit (M)       \%        33.2--50.5                  37.1--51.4                            40--50                                  35.0--50.8                                      40.2--53.7                           41.0--53.0
  Haematocrit (F)       \%        26.4--45.0                  29.1--43.6                            30--50                                  29.4--45.4                                      36.2--46.8                           36.0--46.0
  RBC (M)            ×10^12^/L    3.79--5.96                      NA                               4.4--6.3                                  4.0--6.4                                       4.41--6.27                            4.5--5.9
  RBC (F)            ×10^12^/L    3.09--5.30                      NA                               3.7--5.6                                  3.8--5.6                                       3.84--5.59                            4.0--5.2
  MCV                   fl          72--97                        NA                                69--97                                    68--98                                          78--98                              80--100
  MCH                   pg        22.6--33.5                      NA                              22.4--33.5                                    NA                                          23.6--33.1                           26.0--34.0
  MCHC                 g/dL       30.5--36.2                      NA                              32.2--33.5                                    NA                                          30.6--34.9                           31.0--37.0
  Platelets (M)      ×10^9^/L       88--352                     97--356                            115--366                                  150--350                                        147--356                             150--350
  Platelets (F)      ×10^9^/L       89--403                    118--385                            124--444                                  150--350                                        151--425                             150--350
  WBC, Total         ×10^9^/L      3.4--9.2                    3.4--8.8                            2.8--8.4                                  3.1--9.1                                        3.0--7.9                            4.5--11.0

NA, Not Available.

10.1371/journal.pone.0036308.t006

###### Comparison of adult biochemical reference values obtained from this study against others.

![](pone.0036308.t006){#pone-0036308-t006-6}

  Analyte               Unit    Present Study   Southern Ghana [@pone.0036308-Koram1]   Kenya [@pone.0036308-Kibaya1]   Tanzania [@pone.0036308-Saathoff1]   USA [@pone.0036308-Kratz1]
  ------------------- -------- --------------- --------------------------------------- ------------------------------- ------------------------------------ ----------------------------
  Sodium               mmol/L     135--150                    138--146                            141--153                           134--143                         136--145
  Potassium            mmol/L     3.6--5.2                    3.1--4.6                            3.9--5.8                           3.8--5.5                         3.5--5.0
  Chloride             mmol/L     102--114                       NA                               101--112                           98--107                          98--106
  Urea                 mmol/L     0.9--5.7                    1.7--7.2                            1.4--4.6                           1.5--5.0                         3.6--7.1
  Creatinine, M        µmol/L      56--119                     81--141                             62--106                            48--96                           \<133
  Creatinine, F        µmol/L      47--110                     70--121                             51--91                             40--81                           \<133
  ALT (M+F)             U/L         7--51                        NA                                10--52                             8--48                            0--35
  ALT, M                U/L         8--54                      12--53                              11--54                             9--55                            0--35
  ALT, F                U/L         6--51                      10--39                               9--47                             7--45                            0--35
  AST, (M+F)            U/L        14--51                        NA                                14--42                             14--48                           0--35
  AST, M                U/L        17--60                      19--65                              15--45                             15--53                           0--35
  AST, F                U/L        13--48                      16--47                              13--38                             14--35                           0--35
  ALP, (M+F)            U/L        85--242                       NA                                  NA                              46--158                          30--120
  ALP, M                U/L       101--353                    124--479                               NA                              45--170                          30--120
  ALP, F                U/L        82--293                     98--316                               NA                              45--155                          30--120
  GGT                   U/L         7--61                        NA                                  NA                               8--108                           1--94
  Bilirubin, Total     µmol/L     2.9--25.8                   1.7--27.0                           4.9--39.9                         5.2--41.0                        5.1--17.0
  Bilirubin, Direct    µmol/L     0.8--4.0                    3.4--10.3                           1.1--8.8                           0.7--8.2                         1.7--5.1
  Albumin               g/dL     33.0--49.9                    46--68                            35.8--48.1                         35.6--50.4                         35--55
  Total Protein         g/dL       51--87                        NA                                  NA                               66--85                           55--80
  Cholesterol          mmol/L     2.0--5.4                       NA                               2.6--5.7                           2.5--5.5                          \<5.17
  Triglyceride         mmol/L     0.4--2.2                       NA                               0.4--2.6                           0.4--2.9                          \<1.8
  Uric Acid (M)        µmol/L     123--418                       NA                                  NA                              196--459                         150--480
  Uric Acid (F)        µmol/L      83--381                       NA                                  NA                              148--360                         90--360
  Glucose (Fasting)    mmol/L     3.6--6.4                       NA                               3.1--5.7                           2.9--5.2                         4.2--6.4
  Phosphorus           mmol/L    0.73--1.45                      NA                                  NA                              0.7--1.5                         1.0--1.4
  Iron                 µmol/L     5.5--30.6                      NA                                  NA                                 NA                             9--27
  Amylase               U/L        32--139                       NA                                38--163                           43--164                          60--180
  LDH                   U/L       223--681                       NA                               126--264                           127--264                         100--190

10.1371/journal.pone.0036308.t007

###### Analytical precision for haematology assays.

![](pone.0036308.t007){#pone-0036308-t007-7}

  Analyte                          Between-Run Precision   ABX Precision         
  ------------------------------- ----------------------- --------------- ------ ------
  Haemoglobin                              13.4                0.27        2.02   3.33
  Haematocrit                              38.3                1.02        2.65   2.47
  Red Blood Cell Count (RBC)               4.73                0.09        1.91   1.24
  Platelets                                 281                17.75       6.31   10.1
  White Blood Cell, Total (WBC)             7.4                0.19        2.64   1.9

10.1371/journal.pone.0036308.t008

###### Methods and analytical precision for clinical chemistry assays.

![](pone.0036308.t008){#pone-0036308-t008-8}

  Analyte                                              Method                     Between-Run Precision   Producer\'s Precision[\*](#nt109){ref-type="table-fn"}               
  ---------------------------------- ------------------------------------------- ----------------------- -------------------------------------------------------- ----- ------ -----
  Alanine Aminotransterase (ALT)      IFCC Modified without pyridoxal phosphate           44.5                                     1.5                             3.5    57    4.6
  Aspartate aminotransterase (AST)    IFCC Modified without pyridoxal phosphate           49.5                                     3.0                             6.0    46    6.3
  Alkaline Phosphatase (ALP)          *p*-Nitrophenyl phosphate. Diethanolamine           160.3                                    7.4                             4.6    33    5.1
  Amylase                              2-chloro-4-nitrophenyl-α-maltotrioside             56.3                                     1.6                             2.8    92    2.5
  Creatine kinase, Total                  IFCC, UV Kinetic/Imidazole Buffer               149.4                                    9.1                             6.1    49    4.4
  Gamma glutamyltransferase (GGT)      L-γ-Glutamyl-3-carboxy-*p*-nitroanilide            36.4                                     1.4                             3.9    28    4.5
  Lactate dehydrogenase (LDH)             UV kinetic (Pyruvate to Lactate)                 309                                     10.8                            3.5   333    3.9
  Protein, Total                                   Biuret/endpoint                        66.7                                     2.4                             3.7    38    4.7
  Albumin                                Bromocresol green- Succinate Buffer              46.4                                     1.3                             2.7    27    2.6
  Bilirubin, Total                        Malloy-Evelyn modified. End point               24.8                                     0.9                             3.7   16.9   3.3
  Bilirubin, Direct                       Malloy-Evelyn modified. End point               10.1                                     0.7                             7.2   10.9   3.5
  Cholesterol                              Cholesterol Oxidase/Peroxidase                  2.2                                     0.1                             4.0   3.3    3.8
  Glucose                                    Glucose oxidase/Peroxidase                    5.3                                     0.2                             4.6   5.1    3.5
  Iron                                               Chromazurol                          22.0                                     1.1                             4.9   19.9   5.4
  Triglyceride                              Lipase/GK/GPO/Peroxidase/dye                   1.1                                     0.1                             4.3   1.3    4.3
  Urea                                         Enzymatic --UV Kinetic                      7.6                                     0.4                             5.4   9.8    4.5
  Creatinine                                        Jaffé-Kinetic                         96.1                                     3.8                             3.9   136    4.9
  Uric acid                                      Uricase/Peroxidase                        275                                     12.5                            4.6   286    1.8
  Chloride                                           ISE, Direct                          107.4                                    1.4                             1.3    NP    2.0
  Phosphorus                                 Phosphomolybdate formation                    1.3                                     0.1                             4.2   1.44   2.8
  Potassium                                          ISE, Direct                           4.7                                     0.1                             2.9    NP    3.0
  Sodium                                             ISE, Direct                           148                                     2.0                             1.3    NP    2.0

SD = Standard Deviation; CV = Coefficient of variation; NP = Not provided.

Chloride, Potassium and Sodium by Human Diagnostics, Germany; Others by Elitech Diagnostics, France.

Discussion {#s4}
==========

This study aimed at establishing haematological and biochemical reference values to serve as standards for the interpretation of laboratory results during screening and follow-ups in clinical trials and routine healthcare in the Kintampo area. The results obtained from the Kintampo area demonstrated that the red blood cell parameters (haemoglobin, haematocrit and RBC counts) were lower than values set as standards on the clinical haematology machines being used for clinical trials assessments in the study area. Such variations are expected for populations in different geographical/ecological locations; the recommendations of the manufacturers for each laboratory to establish its own reference values based upon the local population [@pone.0036308-ABX1] has been proved beneficial. Values in the manual accompanying the haematology analyzer were defined using a population in New Jersey, USA. It is of interest to document also that the values obtained from our study were on most occasions far lower than those of other western industrialized countries [@pone.0036308-Kratz1], [@pone.0036308-Wakeman1]. Similar observations have been made in studies carried out in Mampong Akuapem in southern Ghana [@pone.0036308-Koram1]; Kericho in Kenya [@pone.0036308-Kibaya1]; in southern and eastern Africa [@pone.0036308-Karita1]; in Saudi Arabia [@pone.0036308-Scott1], Erzurum; in Turkey [@pone.0036308-Kaya1] as well as Pakistan [@pone.0036308-Usman1]. These lower values for areas in sub-Saharan Africa have been attributed to factors such as poor nutritional status, genetic red blood cell disorders (such as sickle cell trait) or parasitic infections including schistosomiasis or malaria [@pone.0036308-Karita1]. No differences were observed in both haemoglobin and haematocrit values obtained in this study and that of the populations of southern Ghana [@pone.0036308-Koram1]. A similar survey in the northern part of Ghana will help inform the scientific community about how much generalization one can make using the Kintampo area study results. The haemoglobin levels were, however, higher in this survey than those obtained from other populations in Kericho, Kenya [@pone.0036308-Kibaya1].

Significant gender differences were documented for the RBC parameters (haemoglobin, haematocrit and RBC), and this is consistent with an already-established knowledge that males have higher values for these parameters than females [@pone.0036308-Lugada1], [@pone.0036308-Wakeman1], [@pone.0036308-Kaya1], [@pone.0036308-Saathoff1], [@pone.0036308-Menard1]. The reasons for these differences have been attributed to factors such as the influence of the androgen hormone on erythropoiesis and menstrual blood loss in females [@pone.0036308-Kibaya1], [@pone.0036308-Menard1]. The demonstration of significantly higher platelet values in females than males supports findings from previous studies [@pone.0036308-Koram1], [@pone.0036308-Wakeman1], [@pone.0036308-Kibaya1]. Platelet and WBC values documented in this study were generally lower compared with the values in the instrument manual as well as values reported by Kratz *et al.* [@pone.0036308-Kratz1] in the US and Wakeman *et al.* [@pone.0036308-Wakeman1] in the UK. The values from this study were however similar to those reported in southern Ghana [@pone.0036308-Koram1] and many other African countries [@pone.0036308-Menard1], [@pone.0036308-Azikiwe1], [@pone.0036308-Gill1], [@pone.0036308-Tsegaye1]. The cause(s) of lower platelet counts in Africans is not known [@pone.0036308-Lugada1]; however, the lower platelet values in our studies could be due to genetic factors [@pone.0036308-Bain1] or increased consumption of platelets as a result of malaria infection in our study areas [@pone.0036308-Hoffbrand1].

The most commonly requested haematology parameters for screening/enrolment of participants and monitoring safety during clinical trials are haemoglobin, haematocrit, total WBC and platelet counts [@pone.0036308-Asante1], [@pone.0036308-OwusuAgyei1], [@pone.0036308-OwusuAgyei2]. The proportion of OOR values for these four parameters ranged between 16.1% and 53%. This means based on the previous reference values used in the study area, up to 53% of potential study participants would have been declared as having abnormal results or enrolled participants would be reported as having adverse events (AEs). In the area of clinical management of patients, a patient requiring a particular treatment may be denied it whiles one who does not need treatment would end up being treated due to the use of inappropriate reference values. In other studies, the OOR values for these parameters were up to 29% [@pone.0036308-Karita1] and 44% [@pone.0036308-Saathoff1] when the locally derived values were compared with US data.

Findings of significantly higher values in males than females for the following biochemical parameters (ALT, AST, ALP, Bilirubin, CK, GGT, iron, creatinine, urea), and vice versa for uric acid is generally supported by other studies [@pone.0036308-Koram1], [@pone.0036308-Kibaya1], [@pone.0036308-Saathoff1] as shown in [Table 6](#pone-0036308-t006){ref-type="table"}. The urea levels were low when compared to the values from the reagent inserts of Elitech Diagnostics and the US values [@pone.0036308-Kratz1]. However the results from this study were comparable to those from other African countries [@pone.0036308-Kibaya1], [@pone.0036308-Saathoff1] and from Saudi nationals [@pone.0036308-Scott1].

Biochemical tests commonly used during screening/enrollment and safety monitoring of trial participants in the Kintampo study area are ALT, AST, Bilirubin (Total and Direct), Urea and Creatinine. The proportion of OOR values for these parameters was up to 32% in our study, compared to up to 42% in Kenya [@pone.0036308-Karita1] and up to 81% in Tanzania [@pone.0036308-Saathoff1]. The concern is about the levels of disqualification from screening/enrolment into clinical trials and mis-interpretations of AEs. Using the western values, we will report laboratory AEs in essentially normal volunteers, with the potential to ruin a trial (based on AEs) where there is no problem as such. Similar findings of higher ALT and AST values have been reported in south India [@pone.0036308-Furruqh1]. Although the definite cause of higher liver enzymes in our population is unknown, there is the possibility of this being due to subclinical viral infections or the levels of usage of herbal preparations as discussed in earlier publications [@pone.0036308-Koram1]. Screening for Hepatitis viruses was not performed in this study. However, published data on prevalence of these viruses among Ghanaian blood donors is 7 to 15% for Hepatitis B virus [@pone.0036308-Nkrumah1], [@pone.0036308-Sarkodie1] and 7 to 11% for Hepatitis C virus [@pone.0036308-Nkrumah1]. On the use of herbal preparations, it has been estimated that the first line treatment for 60% of children with fever resulting from malaria in Ghana, Mali, Nigeria and Zambia is the use of herbal medicine at home [@pone.0036308-Peltzer1].

Between-run test measures a method\'s overall precision as it measures the random error inherent in the method from day to day. It takes into account variable factors such as changes in reagents, operators and ambient operating conditions. Between-run precision for haemoglobin and platelets were within precision limits quoted in the analyser manual. Although the CVs for the other analytes were higher (i.e. haematocrit 2.65 against 2.47%, RBC 1.91 against 1.24% and WBC 2.64 against 1.9%), they were within the Clinical Laboratory Improvement Act (CLIA) acceptable test performance criteria [@pone.0036308-Clinical1]. These 5 parameters are presented for haematology because they are the measured analytes from which the others are derived. Majority of the clinical chemistry tests were also within the precision limits indicated by the reagent producers. The precision of all the analytes were within the CLIA acceptable performance criteria limits. This precision data supports the reliability of the reference values established by this study.

Conclusion {#s4a}
----------

The reference values developed for the Kintampo study area will be of immense benefit to most clinical trials requiring monitoring of haematological and biochemical parameters and patient care in general. Compared to other references, the reference values for haemoglobin, haematocrit, red blood cell counts and urea are lower in the Kintampo study area.
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